Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 6661 AL 6675

Alzheimer's disease blood-based biomarker testing: A stakeholder-informed assessment of coverage considerations

Deverka PA, Arias JJ, Lin GA, Zwerling J, Phillips KA.

J Alzheimers Dis. 2025 May;105(2):433-442. doi: 10.1177/13872877251329394. Epub 2025 Apr 1.

Alzheimer's Disease Clinical Trials: What Have We Learned From Magnetic Resonance Imaging

By S, Kahl A, Cogswell PM.

J Magn Reson Imaging. 2025 Feb;61(2):579-594. doi: 10.1002/jmri.29462. Epub 2024 Jun 20.

Plasma adiponectin and biomarker-confirmed Alzheimer's disease in a tertiary memory clinic

Sindzingre L, Bouaziz-Amar E, Mouton-Liger F, Cognat E, Dumurgier J, Götze K, Martinet M, Vrillon A, Paquet C, Lilamand M.

J Neuroendocrinol. 2025 Apr;37(4):e13493. doi: 10.1111/jne.13493. Epub 2025 Jan 22.

Unveiling blood biomarkers for neuronal hyperplasticity: Insights from AD molecular subtyping, a comprehensive review

Sharma N, Kim D, Sharma H, Kim MI, Lee H, Kim M, Ryoo N, Kang MJ, Pyun JM, Park YH, Ryu J, Oh HJ, Yang HS, Kim HR, Kim GH, Han S, Yang Y, Youn YC, Teunissen C, Zetterberg H, Scheltens P, An SSA, Kim YB, Kim S; Alzheimer's Disease All Markers (ADAM) Research Group.

Alzheimers Dement. 2025 Jul;21(7):e70475. doi: 10.1002/alz.70475.

Pulse pressure as a predictor of Alzheimer's disease biomarkers and cognitive decline: The moderating role of APOE ε4

Jung JH, Kong N, Lee S; A4 and LEARN Study Teams.

J Prev Alzheimers Dis. 2025 Dec;12(10):100363. doi: 10.1016/j.tjpad.2025.100363. Epub 2025 Sep 3.

The Effect of APOE ε4 on Alzheimer's Disease Fluid Biomarkers: A Cross-Sectional Study Based on the COAST

Zhao B, Zang P, Quan M, Wang Q, Guo D, Jia J, Wang W.

CNS Neurosci Ther. 2025 Jan;31(1):e70202. doi: 10.1111/cns.70202.

Prospective use of miRNAs as biomarkers in the diagnosis of Alzheimer's disease

Haśko A, Potocka N, Skrzypa M, Bartosik-Psujek H, Zawlik I.

Adv Clin Exp Med. 2025 Jun;34(6):1025-1037. doi: 10.17219/acem/190273.

[Differential diagnosis of Alzheimer's disease and vascular cognitive disorders]

Cherdak MA, Mkhitaryan EA, Tkacheva ON.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(4. Vyp. 2):26-35. doi: 10.17116/jnevro202512504226.

Spatial Dissociation of Atrophy and Hypophysiology in Alzheimer's Disease: Implications for Biomarkers

Dang A, Wang D, Towne JM, Seshadri S, Habes M, Fox PT.

Hum Brain Mapp. 2025 Nov;46(16):e70402. doi: 10.1002/hbm.70402.

Cutting through the noise: A narrative review of Alzheimer's disease plasma biomarkers for routine clinical use

Schöll M, Vrillon A, Ikeuchi T, Quevenco FC, Iaccarino L, Vasileva-Metodiev SZ, Burnham SC, Hendrix J, Epelbaum S, Zetterberg H, Palmqvist S.

J Prev Alzheimers Dis. 2025 Apr;12(4):100056. doi: 10.1016/j.tjpad.2024.100056. Epub 2025 Jan 14.

The coupling of global brain activity and cerebrospinal fluid flow as a potential predictive marker of brain amyloid-β accumulation

Tanaka Y, Kamagata K, Saito Y, Takabayashi K, Iseki R, Uchida W, Andica C, Hagiwara A, Wada A, Akashi T, Abe O, Aoki S; Alzheimer’s Disease Neuroimaging Initiative.

J Prev Alzheimers Dis. 2025 Sep;12(8):100228. doi: 10.1016/j.tjpad.2025.100228. Epub 2025 Jun 13.

The role of exosomes in diagnosis, pathophysiology, and management of Alzheimer's Disease

Daksh R, Mathew MS, Bosco AM, Sojan C, Tom AA, Bojja SL, Nampoothiri M.

Biochem Biophys Res Commun. 2025 Mar 25;754:151526. doi: 10.1016/j.bbrc.2025.151526. Epub 2025 Feb 21.

From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer's Disease Landscape

Bougea A, Debasa-Mouce M, Gulkarov S, Castro-Mosquera M, Reiss AB, Ouro A.

Medicina (Kaunas). 2025 Aug 14;61(8):1462. doi: 10.3390/medicina61081462.

Disclosure of Alzheimer's disease blood-based biomarker results in a primary care setting: Opportunities and challenges

Bolton CJ, Rostamzadeh A, Chin N, Fowler NR, Heidebrink J, Rahman-Fillipiak A, Romano RR 3rd, Clark LR; Advisory Group on Risk Evidence Education in Dementia (AGREEDementia).

J Prev Alzheimers Dis. 2025 Nov;12(9):100310. doi: 10.1016/j.tjpad.2025.100310. Epub 2025 Jul 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias